��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s disease: A Post-hoc Analysis

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 026

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mahnaz Asgharnejad, PharmD (Takeda Pharmaceuticals) PRESENTER	Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Lars Bauer, MD (UCB Biosciences GmbH)	No disclosure on file
	No disclosure on file
	No disclosure on file
Stephen K. Van Den Eeden, PhD (Kaiser Permanente)	Dr. Van Den Eeden has received personal compensation for serving as an employee of Kaiser Permanente Northern California. The institution of Dr. Van Den Eeden has received research support from NIH. The institution of Dr. Van Den Eeden has received research support from Biogen. The institution of Dr. Van Den Eeden has received research support from MJFF. The institution of an immediate family member of Dr. Van Den Eeden has received research support from NIH.